Authors:
KOBAYASHI R
WATANABE N
IGUCHI A
CHO Y
YOSHIDA M
ARIOKA H
NAITO H
SHIKANO T
ISHIKAWA Y
Citation: R. Kobayashi et al., ELECTROENCEPHALOGRAM ABNORMALITY AND HIGH-DOSE BUSULFAN IN CONDITIONING REGIMENS FOR STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21(3), 1998, pp. 217-220
Authors:
FUKUMOTO H
NISHIO M
NISHIO K
HEIKE Y
ARIOKA H
KUROKAWA H
ISHIDA T
FUKUOKA K
NOMOTO T
OHE Y
SAIJO N
Citation: H. Fukumoto et al., INTERFERON-GAMMA-INDUCING FACTOR GENE TRANSFECTION INTO LEWIS-LUNG-CARCINOMA CELLS REDUCES TUMORIGENICITY IN-VIVO, Japanese journal of cancer research, 88(5), 1997, pp. 501-505
Authors:
KUROKAWA H
NISHIO K
ISHIDA T
ARIOKA H
FUKUOKA K
NOMOTO T
FUKUMOTO H
YOKOTE H
SAIJO N
Citation: H. Kurokawa et al., EFFECT OF GLUTATHIONE DEPLETION ON CISPLATIN RESISTANCE IN CANCER-CELLS TRANSFECTED WITH THE GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE, Japanese journal of cancer research, 88(2), 1997, pp. 108-110
Authors:
OGASAWARA H
NISHIO K
ISHIDA T
ARIOKA H
FUKUOKA K
SAIJO N
Citation: H. Ogasawara et al., IN-VITRO ENHANCEMENT OF ANTITUMOR-ACTIVITY OF A WATER-SOLUBLE DUOCARMYCIN DERIVATIVE, KW-2189, BY CAFFEINE-MEDIATED DNA-REPAIR INHIBITION IN HUMAN LUNG-CANCER CELLS, Japanese journal of cancer research, 88(11), 1997, pp. 1033-1037
Authors:
FUKUOKA K
ADACHI J
NISHIO K
ARIOKA H
KUROKAWA H
FUKUMOTO H
ISHIDA T
NOMOTO T
YOKOTE H
TOMONARI A
NARITA N
YOKOTA J
SAIJO N
Citation: K. Fukuoka et al., P16(INK4) EXPRESSION IS ASSOCIATED WITH THE INCREASED SENSITIVITY OF HUMAN NONSMALL CELL LUNG-CANCER CELLS TO DNA TOPOISOMERASE-I INHIBITORS, Japanese journal of cancer research, 88(10), 1997, pp. 1009-1016
Citation: H. Arioka et al., IN-VITRO AND IN-VIVO MODULATION BY RHIZOXIN OF NON-P-GLYCOPROTEIN-MEDIATED VINDESINE RESISTANCE, Journal of cancer research and clinical oncology, 123(4), 1997, pp. 195-200
Authors:
ISHIDA T
NISHIO K
KUROKAWA H
ARIOKA H
FUKUMOTO H
FUKUOKA K
NOMOTO T
YOKOTE H
HASEGAWA S
SAIJO N
Citation: T. Ishida et al., CIRCUMVENTION OF GLUTATHIONE-MEDIATED MITOMYCIN-C RESISTANCE BY A NOVEL MITOMYCIN-C ANALOG, KW-2149, International journal of cancer, 72(5), 1997, pp. 865-870
Authors:
TOMONARI A
NISHIO K
KUROKAWA H
ARIOKA H
ISHIDA T
FUKUMOTO H
FUKUOKA K
NOMOTO T
IWAMOTO Y
HIEKE Y
ITAKURA M
SAIJO N
Citation: A. Tomonari et al., IDENTIFICATION OF CIS-ACTING DNA ELEMENTS OF THE HUMAN GAMMA-GLUTAMYLCYSTEINE SYNTHETASE HEAVY SUBUNIT GENE, Biochemical and biophysical research communications, 232(2), 1997, pp. 522-527
Authors:
FUKUDA M
INOMATA M
NISHIO K
FUKUOKA K
KANZAWA F
ARIOKA H
ISHIDA T
FUKUMOTO H
KUROKAWA H
OKA M
SAIJO N
Citation: M. Fukuda et al., A TOPOISOMERASE-II INHIBITOR, NK109, INDUCES DNA SINGLE-STRAND AND DOUBLE-STRAND BREAKS AND APOPTOSIS, Japanese journal of cancer research, 87(10), 1996, pp. 1086-1091
Authors:
SAIJO N
NISHIO K
OHTA S
ARIOKA H
FUNAYAMA Y
FUKUOKA K
KUROKAWA H
NOMOTO T
ISHIDA T
YAMAMOTO N
TAMURA T
SHINKAI T
EGUCHI K
OHE Y
KUNITO H
OHTSU T
SASAKI Y
Citation: N. Saijo et al., PROGRESS IN PRECLINICAL AND CLINICAL-STUDIES FOR THE DEVELOPMENT OF NEW ANTICANCER DRUGS IN JAPAN, WITH EMPHASIS ON TAXANES, Cancer chemotherapy and pharmacology, 38, 1996, pp. 11-15
Authors:
NISHIO K
ISHIDA T
ARIOKA H
KUROKAWA H
FUKUOKA K
NOMOTO T
FUKUMOTO H
YOKOTE H
SAIJO N
Citation: K. Nishio et al., ANTITUMOR EFFECTS OF BUTYROLACTONE-I, A SELECTIVE CDC2 KINASE INHIBITOR, ON HUMAN LUNG-CANCER CELL-LINES, Anticancer research, 16(6B), 1996, pp. 3387-3395
Authors:
OHIRA T
NISHIO K
OHE Y
ARIOKA H
NISHIO M
FUNAYAMA Y
OGASAWARA H
FUKUDA M
YAZAWA K
KATO H
SAIJO N
Citation: T. Ohira et al., IMPROVEMENT BY EICOSANOIDS IN CANCER CACHEXIA INDUCED BY LLC-IL6 TRANSPLANTATION, Journal of cancer research and clinical oncology, 122(12), 1996, pp. 711-715
Authors:
OHIRA T
NISHIO K
KANZAWA F
ISHIDA T
OHE Y
ARIOKA H
FUNAYAMA Y
OGASAWARA H
KATO H
SAIJO N
Citation: T. Ohira et al., HYPERSENSITIVITY OF NIH3T3 CELLS TRANSFORMED BY H-RAS GENE TO DNA-TOPOISOMERASE-I INHIBITORS, International journal of cancer, 67(5), 1996, pp. 702-708
Authors:
FUKUDA M
NISHIO K
KANZAWA F
OGASAWARA H
ISHIDA T
ARIOKA H
BOJANOWSKI K
OKA M
SAIJO N
Citation: M. Fukuda et al., SYNERGISM BETWEEN CISPLATIN AND TOPOISOMERASE-I INHIBITORS, NB-506 AND SN-38, IN HUMAN SMALL-CELL LUNG-CANCER CELLS, Cancer research, 56(4), 1996, pp. 789-793
Authors:
OSHITA F
ARIOKA H
HEIKE Y
SHIRAISHI J
SAIJO N
Citation: F. Oshita et al., CORRELATION OF GENE-SPECIFIC DAMAGE WITH CISPLATIN BETWEEN HUMAN ADENOCARCINOMA CELLS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS ANALYZED BY POLYMERASE CHAIN REACTION-STOP ASSAY, Japanese journal of cancer research, 86(2), 1995, pp. 233-238
Authors:
HEIKE Y
TAKAHASHI M
OHIRA T
ARIOKA H
FUNAYAMA Y
NISHIO K
OGASAWARA H
SAIJO N
Citation: Y. Heike et al., IN-VIVO SCREENING MODELS OF CISPLATIN-RESISTANT HUMAN LUNG-CANCER CELL-LINES USING SCID MICE, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 200-204
Authors:
ISHIKAWA Y
KOBAYASHI R
ARIOKA H
CHO Y
ITOH T
Citation: Y. Ishikawa et al., ALTERNATE-DAY CYCLOSPORINE-A TREATMENT FOR PATIENTS WITH APLASTIC-ANEMIA, Experimental hematology, 23(8), 1995, pp. 914-914
Authors:
NAKASHIMA H
LIEBERMAN R
KARATO A
ARIOKA H
OHMATSU H
NOMURA N
SHIRAISHI J
TAMURA T
EGUCHI K
SHINKAI T
SASAKI Y
YAMAMOTO N
HUKUDA M
OSHITA F
OHE Y
SAIJO N
Citation: H. Nakashima et al., EFFICIENT SAMPLING STRATEGIES FOR FORECASTING PHARMACOKINETIC PARAMETERS OF IRINOTECAN (CPT-11) - IMPLICATION FOR AREA UNDER THE CONCENTRATION-TIME CURVE MONITORING, Therapeutic drug monitoring, 17(3), 1995, pp. 221-229
Authors:
NISHIO K
ARIOKA H
ISHIDA T
FUKUMOTO H
KUROKAWA H
SATA M
OHATA M
SAIJO N
Citation: K. Nishio et al., ENHANCED INTERACTION BETWEEN TUBULIN AND MICROTUBULE-ASSOCIATED PROTEIN-2 VIA INHIBITION OF MAP KINASE AND CDC2 KINASE BY PACLITAXEL, International journal of cancer, 63(5), 1995, pp. 688-693
Authors:
KUROKAWA H
ISHIDA T
NISHIO K
ARIOKA H
SATA M
FUKUMOTO H
MIURA M
SAIJO N
Citation: H. Kurokawa et al., GAMMA-GLUTAMYLCYSTEINE SYNTHETASE GENE OVEREXPRESSION RESULTS IN INCREASED ACTIVITY OF THE ATP-DEPENDENT GLUTATHIONE S-CONJUGATE EXPORT PUMP AND CISPLATIN RESISTANCE, Biochemical and biophysical research communications, 216(1), 1995, pp. 258-264
Authors:
SAIJO N
NISHIO K
TAKEDA Y
ARIOKA H
ISHIDA T
NOMOTO T
FUKUOKA K
KUROKAWA H
FUKUMOTO H
Citation: N. Saijo et al., PHORBOL ESTER AND OKADAIC ACID-RESISTANT CELLS - THE CROSSROADS OF SIGNAL-TRANSDUCTION AND DRUG-RESISTANCE, The American journal of medicine, 99, 1995, pp. 35-39
Authors:
SHIKANO T
ARIOKA H
KOBAYASHI R
NAITO H
ISHIKAWA Y
NAKADATE H
HATAE Y
TAKEDA T
Citation: T. Shikano et al., ACUTE LYMPHOBLASTIC-LEUKEMIA AND NON-HODGKINS-LYMPHOMA WITH MEDIASTINAL MASS - A STUDY OF 23 CHILDREN - DIFFERENT DISORDERS OR DIFFERENT STAGES, Leukemia & lymphoma, 13(1-2), 1994, pp. 161-167
Authors:
OHIRA T
OHE Y
HEIKE Y
PODACK ER
OLSEN KJ
NISHIO K
NISHIO M
MIYAHARA Y
FUNAYAMA Y
OGASAWARA H
ARIOKA H
KATO H
SAIJO N
Citation: T. Ohira et al., GENE-THERAPY FOR LEWIS LUNG-CARCINOMA WITH TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-2 CDNAS CO-TRANSFECTED SUBLINE, Gene therapy, 1(4), 1994, pp. 269-275
Authors:
YAMAMOTO N
TAMURA T
KARATO A
UENAKA K
EGUCHI K
SHINKAI T
OHE Y
OSHITA F
ARIOKA H
NAKASHIMA H
SHIRAISHI J
FUKUDA M
HIGUCHI S
SAIJO N
Citation: N. Yamamoto et al., CPT-11 - POPULATION PHARMACOKINETIC MODEL AND ESTIMATION OF PHARMACOKINETICS USING THE BAYESIAN METHOD IN PATIENTS WITH LUNG-CANCER, Japanese journal of cancer research, 85(9), 1994, pp. 972-977
Authors:
OHMATSU H
EGUCHI K
SHINKAI T
TAMURA T
OHE Y
NISIO M
KUNIKANE H
ARIOKA H
KARATO A
NAKASHIMA H
SASAKI Y
TAJIMA K
TADA N
SAIJO N
Citation: H. Ohmatsu et al., A RANDOMIZED CROSS-OVER STUDY OF HIGH-DOSE METOCLOPRAMIDE PLUS DEXAMETHASONE VERSUS GRANISETRON PLUS DEXAMETHASONE IN PATIENTS RECEIVING CHEMOTHERAPY WITH HIGH-DOSE CISPLATIN, Japanese journal of cancer research, 85(11), 1994, pp. 1151-1158